Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
Marasco G, Colecchia A, Bacchi Reggiani ML, Celsa C, Farinati F, Giannini EG, Benevento F, Rapaccini GL, Caturelli E, Di Marco M, Biasini E, Marra F, Morisco F, Foschi FG, Zoli M, Gasbarrini A, Baroni GS, Masotto A, Sacco R, Raimondo G, Azzaroli F, Mega A, Vidili G, Brunetto MR, Nardone G, Dajti E, Ravaioli F, Avanzato F, Festi D, Trevisani F; Italian Liver Cancer (ITA.LI.CA.) group. Marasco G, et al. Among authors: bacchi reggiani ml. Dig Liver Dis. 2021 Aug;53(8):1011-1019. doi: 10.1016/j.dld.2020.12.001. Epub 2021 Jan 19. Dig Liver Dis. 2021. PMID: 33353858
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals.
Ravaioli F, Conti F, Brillanti S, Andreone P, Mazzella G, Buonfiglioli F, Serio I, Verrucchi G, Bacchi Reggiani ML, Colli A, Marasco G, Colecchia A, Festi D. Ravaioli F, et al. Among authors: bacchi reggiani ml. Dig Liver Dis. 2018 Jun;50(6):573-579. doi: 10.1016/j.dld.2018.02.010. Epub 2018 Feb 27. Dig Liver Dis. 2018. PMID: 29567413
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients.
Dajti E, Renzulli M, Colecchia A, Bacchi-Reggiani ML, Milandri M, Rossini B, Ravaioli F, Marasco G, Alemanni LV, Ierardi AM, Carrafiello G, Pinzani M, Azzaroli F, Mazzella G, Golfieri R, Festi D. Dajti E, et al. Among authors: bacchi reggiani ml. Dig Liver Dis. 2022 Jan;54(1):103-110. doi: 10.1016/j.dld.2020.12.114. Epub 2021 Jan 4. Dig Liver Dis. 2022. PMID: 33414086
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
Azzaroli F, Colecchia A, Lodato F, Trerè D, Bacchi Reggiani ML, Festi D, Prati GM, Accogli E, Casanova S, Derenzini M, Roda E, Mazzella G. Azzaroli F, et al. Among authors: bacchi reggiani ml. Aliment Pharmacol Ther. 2006 Jul 1;24(1):129-36. doi: 10.1111/j.1365-2036.2006.02955.x. Aliment Pharmacol Ther. 2006. PMID: 16803611 Free article.
Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment.
Colecchia A, Scaioli E, Montrone L, Vestito A, Di Biase AR, Pieri M, D'Errico-Grigioni A, Bacchi-Reggiani ML, Ravaioli M, Grazi GL, Festi D. Colecchia A, et al. Among authors: bacchi reggiani ml. J Hepatol. 2011 Feb;54(2):300-5. doi: 10.1016/j.jhep.2010.06.037. Epub 2010 Sep 7. J Hepatol. 2011. PMID: 21056498
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation After Direct-Acting Antivirals in HCV Cirrhotic Patients.
Dajti E, Ravaioli F, Colecchia A, Marasco G, Bacchi Reggiani ML, Colli A, Alemanni LV, Tamè M, Andreone P, Brillanti S, Azzaroli F, Mazzella G, Festi D. Dajti E, et al. Among authors: bacchi reggiani ml. Ultraschall Med. 2022 Jun;43(3):280-288. doi: 10.1055/a-1205-0367. Epub 2020 Jul 16. Ultraschall Med. 2022. PMID: 32674184 English.
141 results